Search research articles
Contact Us
Filters
Showing results (811-820 of 816) with videos related to
Page
of 82
Sort By:
You have reached the last page of results.
This site can display upto 816 results.
Cancer Medicine
|
July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Medicine
|
December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
ACS Nano
|
August 8, 2019
Self-Healing Nanophotonics: Robust and Soft Random Lasers
Yun-Tzu Hsu, Chia-Tse Tai, Hsing-Mei Wu, et al.
Cell Reports. Medicine
|
May 2, 2022
An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension
Qian Yu, Yifei Huang, Xiaoguo Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
Chinese Medical Journal
|
April 3, 2023
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
Chengyuan Gu, Zengjun Wang, Tianxin Lin, et al.
Page
of 82
Search research articles
Search
Showing results (811-820 of 816) with videos related to
Sort By:
Page
of 82
You have reached the last page of results.
This site can display upto 816 results.
Cancer Medicine
|
July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Medicine
|
December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial
Feng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
ACS Nano
|
August 8, 2019
Self-Healing Nanophotonics: Robust and Soft Random Lasers
Yun-Tzu Hsu, Chia-Tse Tai, Hsing-Mei Wu, et al.
Cell Reports. Medicine
|
May 2, 2022
An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension
Qian Yu, Yifei Huang, Xiaoguo Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
Chinese Medical Journal
|
April 3, 2023
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
Chengyuan Gu, Zengjun Wang, Tianxin Lin, et al.
Page
of 82